Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
346 Leser
Artikel bewerten:
(1)

Translated Tool from NCCN Measures Mental Health "Temperature" of People with Cancer

The NCCN Distress Thermometer enables discussion and treatment of distress as part of routine care for people with cancer. This free resource is now translated into 46 languages for global accessibility.

PLYMOUTH MEETING, Pennsylvania, July 13, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers in the United States-today announced the NCCN Distress Thermometer has been translated into 46 languages. This free resource helps providers worldwide identify and address the multifactorial aspects of distress cancer patients can experience.

NCCN Distress Thermometer - now available in 46 languages at NCCN.org/global.

NCCN defines "distress" as an unpleasant experience of a mental, physical, social, or spiritual nature that can affect the way people think, feel, or act. Distress may make it harder to cope with having cancer, its symptoms, or its treatment. Using a tool like the NCCN Distress Thermometer normalizes and encourages discussion without any stigma that can cause some patients to avoid talking about psychological or deeply personal issues.

"The NCCN Distress Thermometer acknowledges that undergoing treatment for cancer is distressing for everybody. This simple chart gives patients an easy way to let their doctor know how well they're coping," explained Robert W. Carlson, MD, Chief Executive Officer, NCCN. "We've found that a score of four or higher is an indication for further evaluation and possible intervention. The thermometer includes a corresponding list of problems to help health care providers determine if a patient's distress stems from practical problems, family problems, emotional problems, spiritual/religious concerns, physical problems, or a combination thereof."

The NCCN Distress Thermometer was first created in 1997 by psycho-oncology pioneer Jimmie C. Holland, MD. The late Dr. Holland was Founding Chair of the NCCN Guidelines Panel for Distress Management and Founding President of the American Psychosocial Oncology Society. Her goal was to make discussion of distress a routine part of oncology patient visits in order to improve both the psychosocial and physical well-being of people with cancer.

"Managing a patient's emotional distress as well as physical pain is an essential part of medical treatment," said Dr. Sonali Johnson, Head, Knowledge, Advocacy and Policy, Union for International Cancer Control, the world's largest international cancer-fighting organization, also behind World Cancer Day held every February 4th. "Cancer patients are particularly vulnerable to anxiety and depression, as well as stress at work and at home, all of which can affect their recovery and quality of life. The NCCN Distress Thermometer provides patients and caregivers with a valuable tool in addressing the psychological impact of illness."

The NCCN Distress Thermometer translations are part of ongoing efforts by the NCCN Global Team to make NCCN Guidelines and derivative products more accessible to non-English speakers. More than 100 new translations have published this year alone, including clinical guidelines and patient-friendly versions. NCCN also provides NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework) and NCCN Harmonized Guidelines with optimal recommendations alongside pragmatic approaches to improve treatment in resource-constrained settings, such as low- and middle-income countries. Visit nccn.org/global and join the conversation online with the hashtag NCCNGlobal.

The translated NCCN Distress Thermometer can be found at nccn.org/global/international_adaptations.aspxdistress. Recently-updated NCCN Guidelines for Patients: Distress are also available at nccn.org/patients.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation. NCCN also advances continuing education, global initiatives, policy, and researchcollaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

Photo - https://mma.prnewswire.com/media/1201669/NCCN_DistressThermometer.jpg
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg


Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.